Health
Oxford begins first-of-its-kind trial study to reinfect recovered Coronavirus patients – Republic TV
Oxford to begin its first study of reinfecting recovered patients with the virus. Researchers are looking for 64 healthy, previously Covid-infected volunteers
As Oxford begins its first-of-its-kind trial study that may help to shed light on how to develop a more effective vaccine against the Coronavirus infection, people who have fought off with the COVID-19 virus will be deliberately reinfected. The UK University on Monday said that the researchers are looking for 64 healthy, previously COVID-19 infected volunteers from 18 to 30 years of age to be studied under controlled, quarantine conditions for at least 17 days. Participants will be infected with…
-
General24 hours agoFederal government funding extends cohealth GP services until July 2026
-
General8 hours agoMildura man given 28 years to pay $73,000 in unpaid fines and tolls
-
Noosa News22 hours agoSunshine Coast Airport receives green light for major upgrade opening doors to growth jobs and tourism across the region
-
General11 hours agoAustralia’s race to rewire the country amid a global transmission boom is not unique